This Review provides an update on developments in Janus kinase inhibitors, including new disease indications and adverse effects. The authors discuss issues surrounding selectivity and efficacy, as well as new routes for administration of Janus kinase inhibitors.
- Anniina Virtanen
- Francesca Romana Spinelli
- Massimo Gadina